Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Zwitserland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Nieuws
  7. Persberichten
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť ROCHE HOLDING AG
24/09ROCHE : presents new data at World Muscle Society (WMS) 2021 highlighting new advances for..
AQ
23/09ROCHE : Canadian Blood Services selects Roche Diagnostics Canada as a partner of choice fo..
AQ
22/09ROCHE : launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to..
AQ
21/09ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-Stage Lun..
AQ
20/09ROCHE : Booster programme welcome but plans must be in place for boosters for all vaccinat..
AQ
20/09ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-stage Lun..
BU
20/09ROCHE : New Phase III data support the benefit of Roche's Tecentriq in early-stage lung ca..
AQ
20/09ROCHE : Invitation to Roche's 3rd Quarter Sales 2021 Webinar
PU
17/09ROCHE : receives positive CHMP opinion for Gavretoģ (pralsetinib) for the treatment of adu..
AQ
17/09ROCHE : presents first phase II data on giredestrant, a next generation selective oestroge..
PU
15/09ROCHE : opens access to pathology imaging tools to improve patient care
AQ
09/09ROCHE : signs definitive share purchase agreement with long-term partner TIB Molbiol to ex..
AQ
07/09REMINDER : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
07/09ROCHE : Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Deve..
AQ
07/09ROCHE : to present data from industry leading portfolio at ESMO 2021 showing significant p..
AQ
07/09GENENTECH : to Present Data From Industry-Leading Portfolio at ESMO 2021 Showing Significa..
BU
30/08ROCHE : Partners with the Kolisi Foundation, One By One Target Covid Campaign and Transnet..
BU
30/08ROCHE : Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metasta..
AQ
27/08GENENTECH : Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Tr..
BU
27/08ROCHE : provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-n..
AQ
26/08ROCHE : Shlomo Zalman (Sam) Bregman, a Fox News Commentator, Prominent Rabbi, and Manager ..
AQ
24/08ROCHE : Shape Therapeutics enters into a strategic research collaboration with Roche to ad..
AQ
23/08ROCHE : First monoclonal antibody treatment for COVID-19 approved for use in the UK
AQ
19/08ROCHE : Joint Statement From Unitaid and the World Health Organization (On Behalf of the A..
AQ
18/08JOHNSON & JOHNSON : WHO urges J&J to stop shipping Covid vaccines from Africa to rich coun..
AQ
18/08ROCHE : receives FDA approval for first companion diagnostic to identify dMMR solid tumour..
AQ
09/08ROCHE : Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years t..
AQ
09/08ROCHE : Phase III Study Shows Genentech's Polivy Plus R-CHP Is the First Regimen in 20 Yea..
BU
04/08ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatment for Cert..
AQ
03/08ROCHE : US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment for certa..
AQ
03/08ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatment for Cert..
BU
02/08ROCHE : FDA expands authorized use of REGEN-COV (casirivimab and imdevimab)
PU
30/07ROCHE : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
29/07PTC THERAPEUTICS : Significant Improvements in Survival and Developmental Milestones Demon..
AQ
29/07ROCHE : FDA accepts application for Roche's faricimab for the treatment of neovascular age..
AQ
29/07ROCHE : FDA Accepts Application for Genentech's Faricimab for the Treatment of Wet Age-Rel..
BU
29/07ROCHE : Data for Roche's Evrysdiģ (risdiplam) published in New England Journal of Medicine..
AQ
28/07ROCHE : Data for Genentech's Evrysdi (risdiplam) Published in New England Journal of Medic..
BU
26/07ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Half Year Results..
AQ
22/07ROCHE : Half-year 2021 Investor Update
PU
22/07ROCHE : Half Year Report 2021
PU
22/07ROCHE : reports good half-year results - Investor Update
PU
22/07ROCHE : Half Year 2021 Presentation without appendix
PU
22/07ROCHE : Half Year 2021 Presentation with appendix
PU
22/07ROCHE : reports good half-year results
AQ
21/07ROCHE : FDA Grants Breakthrough Therapy Designation for Venclexta in Combination With Azac..
BU
20/07CHUGAI PHARMACEUTICAL : Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Receives..
AQ
20/07ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with haemophilia ..
AQ
20/07ROCHE : Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for t..
AQ
19/07ROCHE : New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Profile in Pe..
BU
19/07ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with haemophilia ..
AQ
16/07REMINDER : Invitation to Roche's Half Year Results 2021 Presentation
PU
15/07CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishida 'I Wante..
AQ
12/07CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for EOS789 und..
AQ
09/07CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination
AQ
09/07ROCHE : WHO guidelines now include Roche's diagnostic tests in expanded effort to eliminat..
AQ
08/07CHUGAI PHARMACEUTICAL : Files for Additional Indication of Tecentriq for the Adjuvant Trea..
AQ
02/07ROCHE : Media resources for Roche's 125 Years Anniversary
AQ
02/07ROCHE : to present new data at the ISTH 2021 Congress highlighting long-standing commitmen..
AQ
30/06ROCHE : Atea's AT-527, an oral antiviral drug candidate reduces viral replication in hospi..
PU
30/06SUPPORTING CANADA'S BACK TO NORMAL : Roche Diagnostics Canada introduces the new SARS-CoV-..
AQ
29/06CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission as First A..
AQ
28/06ROCHE : ENSPRYNG approved by European Commission as first and only at-home subcutaneous tr..
AQ
25/06CHUGAI PHARMACEUTICAL : Genentech Announces FDA Emergency Use Authorization for Chugai's A..
AQ
25/06ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibizumab for ..
AQ
25/06ROCHE : Invitation to Roche's Half Year Results 2021 Presentation
PU
25/06ROCHE : Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment ..
AQ
25/06GENENTECH : 's Actemra Receives FDA Emergency Use Authorization for the Treatment of COVID..
BU
24/06PTC THERAPEUTICS : Evrysdi Approved in Japan for the Treatment of Spinal Muscular Atrophy
AQ
24/06ROCHE : Title test release to ensure the format looks goood
PU
24/06ROCHE : FDA accepts application for Roche's Port Delivery System with ranibizumab (PDS) fo..
AQ
24/06ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibizumab (PDS..
BU
22/06Insulin pump Accessories Market Development, Outline, Competitive perspective, and Fore..
AQ
17/06ROCHE : Check You Employment Agreement's Restrictive Covenant
AQ
16/06ROCHE : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under L..
AQ
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ROCHE HOLDING AG
28/09/21